Sidia

Daprica S 5/10/50/100

Composition

Dapagliflozin 5/10 mg + Sitagliptin 50/100mg Tablets

Description

Sitagliptin, a member of the islet enhancer class, is a potent and selective dipeptidyl-peptidase-4 (DPP-4) inhibitor that improves glycaemic control. SGLT2 inhibitor (Dapagliflozin) also called gliflozins. Daprica S provides cardio-renal protection, minimal hypoglycaemia & weight reduction.


Sidiamet 500/1000

Composition

Sitagliptin 50 + Metformin 500/1000 mg tablets

Description

In T2DM, Initiate Early, Sitagliptin 50 + Metformin 500/1000 mg tablets. Also available as Sidiamet XR 500/1000 (Sitagliptin 50 mg+ Metformin 500/1000 mg SR Tablets) and Sidiamet XR Forte ( Sitagliptin 100 mg + Metformin 1000 mg SR Tablets)


Sidia 50/100

Composition

Sitagliptin 50/100 mgTablets

Description

Sitagliptin, a member of the islet enhancer class, is a potent and selective dipeptidyl-peptidase-4 (DPP-4) inhibitor that improves glycemic control. Sitagliptin inhibition of DPP-4 results in increased fasting and postprandial endogenous levels of the incretin hormones. The administration of Sitagliptin results in rapid and complete inhibition of DPP-4 activity. In patients with type 2 diabetes, administration of Sitagliptin led to inhibition of DPP-4 enzyme activity for a 24-hours Glycemic Control.